MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort

    O. Ben Othman, S. Frikha, S. Fezai, A. Achouri, M. Ben Mahmoud, H. Jamoussi, S. Fray, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: We aim to study the relationship between clinical features in patients with Parkinson’s disease (PD)  and their IL-6 and IL-1β serum levels. Background: According…
  • 2024 International Congress

    Muscle co-contraction in people with Parkinson’s disease suffering from freezing of gait

    D. Buzaglo, P. Gandhi, Y. Hanein, J. Hausdorff (Tel Aviv, Israel)

    Objective: 1) to test the feasibility of using novel, disposable EMG electrodes to study co-contraction (CC) and 2), to test if muscle CC is higher…
  • 2024 International Congress

    Opportunities for Medical Knowledge Self-Assessment in Movement Disorder Fellowship

    A. Higinbotham, A. Wang, A. Toth, C. Kilbane (Charlottesville, USA)

    Objective: To determine 1) what opportunities for medical knowledge self-assessment exist in movement disorder fellowship training, 2) how satisfied fellows are with such opportunities, and…
  • 2024 International Congress

    How Botulinum Toxin Transformed the American Food Industry

    D. Riley (Cleveland Heights, USA)

    Objective: To highlight an episode of botulism that altered American food packaging technology Background: Early progress in understanding the behavior of botulinum toxin was marked…
  • 2024 International Congress

    Antibody-mediated movement disorders: a single-centre retrospective study

    J. Moura, S. Costa, I. Carrilho, S. Figueiroa, P. Carneiro, E. Neves, J. Damásio, E. Santos, R. Samões (Porto, Portugal)

    Objective: This study aims to evaluate the clinical spectrum of antibody-associated movement disorders from a single centre. Background: There is an increasing recognition of movement…
  • 2024 International Congress

    Tremors Vs. Tremors: the first music album from Parkinson’s tremors

    C. Dore, J. Thomas, S. Rose, J. Leitão, C. Hugill, C. Lambert (London, United Kingdom)

    Objective: Tremors Vs. Tremors is a creative engagement project exploring the intersection between music, mood and tremor. The objective was to raise awareness of Parkinson’s…
  • 2024 International Congress

    Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

    P. Singh, A. Gupta, A. Gupta (Delhi, India)

    Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…
  • 2024 International Congress

    Effect of rehabilitation therapy on the motor functions in patients with multiple system atrophy

    J. Lee, S. Jo, M. Choi, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aim to evaluated the effect of rehabilitation therapy on the motor symptoms and activities of daily living in patients with MSA using an…
  • 2024 International Congress

    The Clinical Implication of Dysphagia in Patients with Multiple System Atrophy

    MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to explore the correlation between dysphagia and key clinical features in Multiple System Atrophy (MSA) patients, along with investigating the link…
  • 2024 International Congress

    Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

    N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

    Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley